Strictly Laboratory Research Use Only: Not approved for human or clinical consumption. HPLC Purity Tested (≥99%).
- In Stock (120 vials available)
- Face Cream
Purity:
RETATRUTIDE (RETA) 30 MG/ML
Vial Size / Concentration:
$90.00
/ vial
Triple-Receptor Metabolic Research Peptide
Retatrutide is an investigational peptide studied for its simultaneous activity at three metabolic hormone receptors: GLP-1, GIP, and glucagon receptors. This triple-agonist mechanism distinguishes retatrutide from single- and dual-receptor incretin compounds.
Research has examined retatrutide in relation to appetite regulation, glucose metabolism, insulin signaling, lipid metabolism, energy intake, and energy expenditure. Its combined receptor activity provides researchers with a unique model for investigating how multiple metabolic signaling pathways interact.
The glucagon-receptor component is of particular interest because it may influence energy expenditure and hepatic metabolism, while GLP-1 and GIP receptor activity is associated with incretin signaling, glucose regulation, and appetite-related pathways.
Clinical research has demonstrated substantial effects on body weight and metabolic markers, while studies continue to characterize its efficacy, safety, and longer-term metabolic effects. Retatrutide remains an investigational compound and is not FDA-approved as of August 2026.
Research Focus: GLP-1 • GIP • Glucagon Receptors • Metabolic Signaling • Appetite Regulation • Glucose Metabolism • Insulin Signaling • Energy Expenditure • Lipid Metabolism • Body-Weight Research
Concentration: Retatrutide — 30 mg/mL
RESEARCH USE ONLY NOT FOR HUMAN OR ANIMAL USE
CAS Number:
Molecular Formula:
Molecular Weight:
Appearance:
ISO 9001:2015 Verified Laboratory Compound
